CBD facing Kratom competition

CBD is facing increasing competition from Kratom, a drug that originated in Southeast Asia and has been used for centuries.

Kratom is a herbal drug that is either chewed, taken via a capsule or can be added to tea for users to drink. In small doses Kratom can behave as a stimulant but in higher doses the drug acts more akin to an opiate.

Associate professor Joseph Palamar of New York University Langone Medical Centre has estimated that 0.7% of the US population had used Kratom in the past year.

This is despite the widespread prevalence of CBD products on the market. CBD remains more popular nationwide however with 40% of people from age 18-29 having tried CBD in the USA.

Kratom’s popularity continues to grow however. Users can take the drug as a replacement for anti-anxiety drug Xanax or the study drug Adderall. Other users have said that Kratom helps manage opiate withdrawal symptoms.

The USA is still recovering from the largest opioid crisis in history thanks to the frequent prescription of opiate related pain killers such as Oxycontin. The drug has been accused of massive deaths throughout the nation from overuse and led many users onto Heroin. Kratom has become a possible withdrawal drug for this issue.

Long term issues related to Kratom use are still unknown but research is ongoing. One positive is that withdrawal from the drug seems to be less severe than other opioids.

Regulation of Kratom remains blurry compared to CBD. In the US it is legal at national level but a “drug of concern” for the Drug Enforcement Administration. Within Europe and the UK the drug is largely difficult to access.

Total
11
Shares
Leave a Reply

Your email address will not be published.

Previous Article

Singapore Olympic star banned due to cannabis

Next Article

More Americans smoke cannabis than cigarettes

Related Posts